These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6238335)

  • 1. Comparative disposition of nafarelin and endogenous luteinizing hormone releasing hormone in female rats.
    Hama KM; Chu NI; Chan RL; Chaplin MD
    Proc West Pharmacol Soc; 1984; 27():303-6. PubMed ID: 6238335
    [No Abstract]   [Full Text] [Related]  

  • 2. Disposition of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in rats and rhesus monkeys.
    Chu NI; Chan RL; Hama KM; Chaplin MD
    Drug Metab Dispos; 1985; 13(5):560-5. PubMed ID: 2865103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical development of nafarelin acetate. Phase I and phase II studies.
    Hoffman PG; Henzl MR; Chaplin MD; Nerenberg CA
    J Androl; 1987; 8(1):S17-22. PubMed ID: 2951357
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of major urinary metabolites of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in the rhesus monkey.
    Chan RL; Chaplin MD
    Drug Metab Dispos; 1985; 13(5):566-71. PubMed ID: 2865104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of luteinizing hormone releasing hormone LH-RH by the hypothalamic and pituitary tissue in the presence of its analogs and TRH.
    Kochman K; Kerdelhué B
    Mater Med Pol; 1980; 12(1-2):114-8. PubMed ID: 6799703
    [No Abstract]   [Full Text] [Related]  

  • 6. Nafarelin in gynecologic use. A symposium.
    Jaffe RB
    J Reprod Med; 1989 Dec; 34(12 Suppl):1017-20. PubMed ID: 2533614
    [No Abstract]   [Full Text] [Related]  

  • 7. Luteinizing hormone releasing hormone (LHRH): II. A new contraceptive agent.
    Rojanasakul A; Nillius SJ
    J Med Assoc Thai; 1986 Jan; 69(1):16-21. PubMed ID: 2937869
    [No Abstract]   [Full Text] [Related]  

  • 8. Nasal absorption of nafarelin acetate, the decapeptide [D-Nal(2)6)]LHRH, in rhesus monkeys. I.
    Anik ST; McRae G; Nerenberg C; Worden A; Foreman J; Hwang JY; Kushinsky S; Jones RE; Vickery B
    J Pharm Sci; 1984 May; 73(5):684-5. PubMed ID: 6234387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone binding to rat anterior pituitary membrane homogenates. Comparison of antagonists and agonists using radiolabeled antagonist and agonist.
    Perrin MH; Haas Y; Rivier JE; Vale WW
    Mol Pharmacol; 1983 Jan; 23(1):44-51. PubMed ID: 6346049
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-tumour potential of a new luteinizing hormone releasing hormone analogue, ICI 118630.
    Nicholson RI; Walker KJ; Maynard PV
    Eur J Cancer (1965); 1980; Suppl 1():295-9. PubMed ID: 6459236
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer.
    Sanders LM; Kell BA; McRae GI; Whitehead GW
    J Pharm Sci; 1986 Apr; 75(4):356-60. PubMed ID: 2941563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of rat mammary tumors by a potent luteinizing hormone-releasing hormone analogue (leuprolide) administered vaginally.
    Okada H; Sakura Y; Kawaji H; Yashiki T; Mima H
    Cancer Res; 1983 Apr; 43(4):1869-74. PubMed ID: 6403230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres.
    Sanders LM; Kent JS; McRae GI; Vickery BH; Tice TR; Lewis DH
    J Pharm Sci; 1984 Sep; 73(9):1294-7. PubMed ID: 6238157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay of nafarelin ([ 6-(3-(2-naphthyl)-D-alanine)]-luteinizing hormone-releasing hormone) in plasma or serum.
    Nerenberg C; Foreman J; Chu N; Chaplin MD; Kushinsky S
    Anal Biochem; 1984 Aug; 141(1):10-6. PubMed ID: 6238549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nafarelin in gynecologic use. A symposium. Rio de Janeiro, Brazil, October 27, 1988. Proceedings.
    J Reprod Med; 1989 Dec; 34(12 Suppl):1017-50. PubMed ID: 2533615
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gonadotropin releasing hormone agonists. A new therapeutic principle in gynecology].
    Tanbo T; Henriksen T; Magnus O; Abyholm T
    Tidsskr Nor Laegeforen; 1988 Jan; 108(2):132-5. PubMed ID: 2965433
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute stimulatory effects of luteinizing hormone-releasing hormone (LHRH) and LHRH analogues on the preovulatory rat follicle.
    Ahrén K; Billig H; Clark MR; Ekholm C; Hillensjö T; LeMaire WJ; Magnusson C; Rani CS
    J Steroid Biochem; 1983 Jul; 19(1A):119-25. PubMed ID: 6350716
    [No Abstract]   [Full Text] [Related]  

  • 18. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
    Carel JC; Eugster EA; Rogol A; Ghizzoni L; Palmert MR; ; Antoniazzi F; Berenbaum S; Bourguignon JP; Chrousos GP; Coste J; Deal S; de Vries L; Foster C; Heger S; Holland J; Jahnukainen K; Juul A; Kaplowitz P; Lahlou N; Lee MM; Lee P; Merke DP; Neely EK; Oostdijk W; Phillip M; Rosenfield RL; Shulman D; Styne D; Tauber M; Wit JM
    Pediatrics; 2009 Apr; 123(4):e752-62. PubMed ID: 19332438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience in the use of nafarelin for treatment of benign breast disease.
    Roberts JV
    Br J Clin Pract Suppl; 1989 Nov; 68():37-42; discussion 49-53. PubMed ID: 2535115
    [No Abstract]   [Full Text] [Related]  

  • 20. Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone.
    Chan RL; Henzl MR; LePage ME; LaFargue J; Nerenberg CA; Anik S; Chaplin MD
    Clin Pharmacol Ther; 1988 Sep; 44(3):275-82. PubMed ID: 2970910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.